Skip to main content
[Preprint]. 2024 Jan 8:rs.3.rs-3346076. [Version 1] doi: 10.21203/rs.3.rs-3346076/v1

Figure 5: Lysophosphatidylcholines (LysoPCs) associated with clinical AD and biomarker positive status.

Figure 5:

In A, the odds ratio (point) and confidence interval (whiskers) of PC1 – 5 in relation to biomarker positive status and clinical AD. In B, the results from analysis stratified by APOE-ε4 allele status. In C, the loadings of lysoPCs on the three PCs (PC1, PC4, and PC5) significantly associated with biomarkers positive status or clinical AD.